下部癌症的放射治疗:2025年更新
Dylan Bocha1, Julian Biau2, Alexandre Coutte3
1Département de radiothérapie, Sainte-Catherine Institut du cancer Avignon-Provence, 250, chemin de Baigne-Pieds, 84918 Avignon, France.
概括
更新的法国指导方针建议强度调节的放射治疗作为下喉癌的标准. 治疗因阶段而异,包括手术,辐射或化学辐射,治疗和预防性放射治疗的具体剂量建议.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 头部和部癌症 头部和部癌症
背景情况:
- 低喉癌的治疗需要更新的建议.
- 强度调节放射治疗 (IMRT) 是已经确立的标准.
研究的目的:
- 介绍法国辐射瘤学会对下喉癌放射治疗的最新指南.
- 根据瘤阶段和特征概述治疗策略.
主要方法:
- 审查和更新现有的放射治疗指南用于下喉癌.
- 包括对早期,局部晚期和T4瘤的建议.
- 治疗和预防性放射治疗的分成表和剂量处方的规范.
- 根据病理学标准考虑术后放射治疗.
主要成果:
- IMRT是对下喉癌的黄金标准.
- 早期的T1/T2瘤:仅限于放射治疗或手术,其次是放射治疗.
- 局部发达的T2/T3瘤:化学辐射或诱导化疗,然后放射.
- T4瘤:建议进行手术.
- 具体的治疗和预防性辐射剂量和分成方案是详细的.
- 术后放射治疗剂量取决于病理发现 (例如,R1切除,外囊扩散).
结论:
- 这些指导方针提供了一个全面的框架,用于放射治疗下喉癌.
- 治疗决策取决于阶段,整合了手术,放射和化疗.
- 剂量分成和处方对于疗效和毒性至关重要,特别是在喉毒性方面.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Vaccines
960
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
960


